Connect
MJA
MJA

Impact of a web-based antimicrobial approval system on broad-spectrum cephalosporin use at a teaching hospital

Michael J Richards, Lyn-Li Lim, Marion B Robertson, Nicholas R Jones, Simone E Taylor, Margarida M Duarte, Dale A Kerr, Graham J Stanton, Peter D Ritchie and Jonathan G A Dartnell
Med J Aust 2003; 178 (8): 386-390.

Summary

Objective: To achieve sustained improvement in use of cefotaxime and ceftriaxone (CEFX) in a major teaching hospital, as measured against national antibiotic guidelines.

Design and setting: Pre- and post-intervention survey of CEFX use in the Royal Melbourne Hospital, a tertiary hospital in Melbourne, Victoria.

Intervention: Web-based antimicrobial approval system linked to national antibiotic guidelines was developed by a multidisciplinary team and implemented in March 2001.

Main outcome measures: Change in rate of CEFX use (defined daily doses [DDDs] per 1000 acute occupied bed days) over 8 months pre- and 15 months post-intervention; concordance of indication for CEFX with national antibiotic guidelines pre- and post-intervention.

Results: CEFX use decreased from a mean of 38.3 DDDs/1000 bed days pre-intervention to 15.9, 18.7 and 21.2 DDDs/1000 bed days at 1, 4 and 15 months post-intervention. Concordance with national antibiotic guidelines rose from 25% of courses pre-intervention to 51% within 5 months post-intervention (P < 0.002). Gentamicin use also increased, from a mean of 30.0 to 48.3 DDDs/1000 bed days (P = 0.0001).

Conclusion: The web-based antimicrobial approval system achieved a sustained reduction in CEFX use over 15 months as well as increased prescribing concordance with antibiotic guidelines. It has potential for linking to electronic prescribing and for wider use for other drugs, as well as for research into the epidemiology of antibiotic use.

Please login with your free MJA account to view this article in full

  • Michael J Richards1
  • Lyn-Li Lim2
  • Marion B Robertson3
  • Nicholas R Jones4
  • Simone E Taylor5
  • Margarida M Duarte6
  • Dale A Kerr7
  • Graham J Stanton8
  • Peter D Ritchie9
  • Jonathan G A Dartnell10

  • 1 Royal Melbourne Hospital, Parkville, VIC.
  • 2 Therapeutic Guidelines Limited, North Melbourne, VIC.

Correspondence: 

Acknowledgements: 

We acknowledge the assistance of Dr Jim Black (Victorian Infectious Diseases Service, Royal Melbourne Hospital) in performing the statistical analysis.

Competing interests:

None identified. Development of the antimicrobial approval system was funded within the budget of the Royal Melbourne Hospital.

  • 1. Joint Expert Technical Advisory Committee on Antibiotic Resistance (JETACAR). The use of antibiotics in food-producing animals: antibiotic-resistant bacteria in animals and humans. Report of JETACAR. Commonwealth Department of Health and Aged Care and Commonwealth Department of Agriculture, Fisheries and Forestry — Australia. Canberra: Ausinfo, 1999. Available at: http://www.health.gov.au/pubs/jetacar.pdf (accessed Mar 2003).
  • 2. Paterson DL, Playford EG. Should third-generation cephalosporins be the empirical treatment of choice for severe community-acquired pneumonia in adults? Med J Aust 1998; 168: 344-348.
  • 3. Ferguson JK. Vancomycin-resistant enterococci: causes and control. Med J Aust 1999; 171: 117-118.
  • 4. Dahms RA, Johnson EM, Statz CL, et al. Third-generation cephalosporins and vancomycin as risk factors for postoperative vancomycin-resistant enterococcus infection. Arch Surg 1998; 133: 1343-1346.
  • 5. Quale J, Landman D, Atwood E, et al. Experience with a hospital-wide outbreak of vancomycin-resistant enterococci. Am J Infect Control 1996; 24: 372-379.
  • 6. Robertson MB, Korman TM, Dartnell JGA, et al. Ceftriaxone and cefotaxime use in Victorian hospitals. Med J Aust 2002; 176: 524-529. <eMJA full text>
  • 7. Writing Group. Therapeutic guidelines: antibiotic. 11th ed. Melbourne: Therapeutic Guidelines Limited, 2000.
  • 8. Clinicians Health Channel. Victorian Government Department of Human Services. Available at: http://www.clinicians.vic.gov.au/ (accessed Mar 2003).
  • 9. Writing Group. Therapeutic guidelines: antibiotic. 10th ed. Melbourne: Therapeutic Guidelines Limited, 1998.
  • 10. Dean A, Dean J, Coulombier D, et al. Epi Info, version 6: a word processing, database, and statistics program for public health on IBM-compatible microcomputers. Atlanta: Centers for Disease Control and Prevention, 1996.
  • 11. Altman D. Practical statistics for medical research. London: Chapman and Hall, 1991.
  • 12. Bero LA, Grilli R, Grimshaw JM, et al. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group. BMJ 1998; 317: 465-468.
  • 13. Dartnell JGA. Activities to improve hospital prescribing. Aust Prescriber 2001; 24: 29-31.
  • 14. Pestotnik SL, Classen DC, Evans RS, Burke JP. Implementing antibiotic practice guidelines through computer-assisted decision support : clinical and financial outcomes. Ann Intern Med 1996; 124: 884-890.
  • 15. Shojania KG, Yokoe D, Platt R, et al. Reducing vancomycin use utilizing a computer guideline: Results of a randomized controlled trial. J Am Med Inform Assoc 1998; 5: 554-562.
  • 16. World Health Organization. WHO global strategy for containment of antimicrobial resistance 2001. Available at: http://www.who.int/emc/amrpdfs/WHO_Global_Strategy_English.pdf (accessed Mar 2003).
  • 17. MacDonald J, Ferguson J. Hospital education influences prescribing at John Hunter Hospital. Aust Prescriber 2001; 24: 32.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.